droxidopa has been researched along with 3,4-dihydroxyphenylacetic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lakke, JP; Muskiet, FA; Staal-Schreinemachers, AL; Teelken, AW; van den Berg, GA; Wolthers, BG | 1 |
| Howes, LG; Louis, WJ; Rowe, PR; Summers, RJ | 1 |
| Maruyama, W; Naoi, M; Narabayashi, H | 1 |
| Goldstein, DS; Heredia-Moya, J; Holmes, C; Whittaker, N | 1 |
| Brinster, LR; Donsante, A; Goldstein, DS; Kaler, SG; Sullivan, P | 1 |
1 trial(s) available for droxidopa and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antiparkinson Agents; Biogenic Monoamines; Cerebral Ventricles; Combined Modality Therapy; Dopamine; Droxidopa; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Reference Values; Stereotaxic Techniques; Thalamus | 1996 |
4 other study(ies) available for droxidopa and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Catecholamines; Dopamine; Droxidopa; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Parkinson Disease, Secondary; Serine | 1989 |
The simultaneous determination of 3,4-dihydroxyphenyl-ethylene glycol, 3,4-dihydroxyphenylacetic acid and catecholamines in brain tissue by high performance liquid chromatography with electrochemical detection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Catecholamines; Chromatography, High Pressure Liquid; Cold Temperature; Dopamine; Droxidopa; Electrochemistry; Epinephrine; Female; Kinetics; Norepinephrine; Phenylacetates; Physical Exertion; Rats; Rats, Inbred Strains; Serine | 1983 |
Contamination of the norepinephrine prodrug droxidopa by dihydroxyphenylacetaldehyde.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Antiparkinson Agents; Chromatography, Liquid; Droxidopa; Drug Contamination; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease | 2010 |
L-threo-dihydroxyphenylserine corrects neurochemical abnormalities in a Menkes disease mouse model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphatases; Animals; Antiparkinson Agents; Blood-Brain Barrier; Brain; Brain Chemistry; Cation Transport Proteins; Copper; Copper-Transporting ATPases; Disease Models, Animal; Dopamine; Dopamine beta-Hydroxylase; Droxidopa; Female; Male; Menkes Kinky Hair Syndrome; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Nerve Degeneration; Norepinephrine | 2013 |